Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism ERAP1 inhibitors(endoplasmic reticulum aminopeptidase 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | GB | 01 Jun 2021 | |
Neoplasms | Preclinical | GB | 01 Jun 2021 |